Paper · 32390854
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation.
Shukla S and 1 other. Front Pharmacol, 2020. Cited by 250 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. Papers, record 32390854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32390854
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References220
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,504,946 | Treatment of spinal muscular atrophy by sodium butyrate. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11504946 | PubMed |
| 2 | 17,320,507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 3 | 24,844,691 | Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice. | J Alzheimers Dis | 2014 | https://conductscience.org/library/papers/24844691 | PubMed |
| 4 | 12,576,549 | Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12576549 | PubMed |
| 5 | 17,468,743 | Recovery of learning and memory is associated with chromatin remodelling. | Nature | 2007 | https://conductscience.org/library/papers/17468743 | PubMed |
| 6 | 19,459,166 | Histone deacetylase inhibitors: Potential in cancer therapy. | J Cell Biochem | 2009 | https://conductscience.org/library/papers/19459166 | PubMed |
| 7 | 19,355,990 | Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders. | Curr Top Med Chem | 2009 | https://conductscience.org/library/papers/19355990 | PubMed |
| 8 | 17,785,525 | HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. | Genes Dev | 2007 | https://conductscience.org/library/papers/17785525 | PubMed |
| 9 | 12,915,451 | Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. | Hum Mol Genet | 2003 | https://conductscience.org/library/papers/12915451 | PubMed |
| 10 | 26,040,297 | Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/26040297 | PubMed |
1 to 10 of 220
See all 220 referencesCited by165
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 250 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,984,960 | Hesperetin improves cognitive impairment in scopolamine-induced C57BL/6 mice. | Food Nutr Res | 2026 | https://conductscience.org/library/papers/42984960 | PubMed |
| 42,980,859 | Oligodendrocyte Lineage Dysfunction in Alzheimer's Disease: A Bidirectional, Stage-Dependent Account. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42980859 | PubMed |
| 42,895,683 | Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42895683 | PubMed |
| 42,875,680 | Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42875680 | PubMed |
| 42,773,171 | Mesoscale proximity labeling at chromatin leads to identification of small molecule mechanism of action. | Nat Commun | 2026 | https://conductscience.org/library/papers/42773171 | PubMed |
| 42,661,118 | From viral epigenetic reprogramming to neuroinflammation: Mechanisms driving neurodegeneration. | J Neurovirol | 2026 | https://conductscience.org/library/papers/42661118 | PubMed |
| 42,536,231 | Oleuropein regulates neuronal survival and Histone acetylation in Parkinson's disease: cellular and epigenetic insights. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42536231 | PubMed |
| 42,423,126 | Sodium Butyrate Attenuates Sevoflurane-Induced Impaired Myelination and Neurobehavioral Deficits in Neonatal Mice via the H3K9ac/BDNF/TrkB Pathway. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42423126 | PubMed |
| 42,389,730 | Resetting the epigenetic clock: cellular senescence and regenerative strategies in intervertebral disc degeneration. | Front Aging | 2026 | https://conductscience.org/library/papers/42389730 | PubMed |
| 42,236,674 | Transcriptional and epigenetic regulation of autophagy: mechanisms, disease relevance and therapeutic opportunities. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42236674 | PubMed |
1 to 10 of 165
See all 165 cited byGenes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AK6 | 102,157,402 | PubTator's text mining | https://conductscience.org/library/genes/102157402 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| CREBBP | 1,387 | PubTator's text mining | https://conductscience.org/library/genes/1387 | NCBI Gene |
| CTTN | 2,017 | PubTator's text mining | https://conductscience.org/library/genes/2017 | NCBI Gene |
| ELP3 | 55,140 | PubTator's text mining | https://conductscience.org/library/genes/55140 | NCBI Gene |
| EP300 | 2,033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
| EPHB2 | 2,048 | PubTator's text mining | https://conductscience.org/library/genes/2048 | NCBI Gene |
| GAP43 | 2,596 | PubTator's text mining | https://conductscience.org/library/genes/2596 | NCBI Gene |
1 to 10 of 46
See all 46 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32390854
GET https://conductscience.org/api/papers/v1/32390854/references?page=2